Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

C3_VAGINA_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C52
  • Hospital discharge: ICD-9 1840
  • Hospital discharge: ICD-8 1840
  • Cause of death: ICD-10 C52
  • Cause of death: ICD-9 1840
  • Cause of death: ICD-8 1840
  • Cancer registry: Topography ICD-O-3 C52
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

106

4. Check minimum number of events

None

106

5. Include endpoints

None

106

6. Filter based on genotype QC (FinnGen only)

106

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

List of similar endpoints to Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 106 106 -
Unadjusted period prevalence (%) 0.04 0.04 -
Median age at first event (years) 63.13 63.13 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
50
Matched controls
499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
35.7
30
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
34.3
29
*
LEB00
NOMESCO Finland
Biopsy of vagina
329.7
31.7
29
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
31.6
27
*
A03FA01
ATC
metoclopramide; systemic, rectal
20.2
18.8
32
40
H02AB02
ATC
dexamethasone; systemic
74.0
17.5
19
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
16.5
15
*
C52.90
ICD-10 Finland
Malignant neoplasm of vagina without histologic examination
+∞
15.4
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.4
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.2
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
14.2
13
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
14.2
13
*
ULA02
NOMESCO Finland
Kolposcopy
15.3
13.2
23
26
C52
ICD-10 Finland
Malignant neoplasm of vagina
+∞
13.1
12
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
153.8
12.0
12
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.9
11
*
C52.99
ICD-10 Finland
Malignant tumor of the vagina, unspecified histology
+∞
11.9
11
*
JN4BD
NOMESCO Finland
Extensive body CT
17.2
11.8
19
17
UKC02
NOMESCO Finland
Cystoscopy
12.5
11.1
21
27
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
10.8
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.8
10
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
10.8
10
*
A04AA01
ATC
ondansetron; systemic, rectal
23.0
10.7
15
9
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
7.8
10.5
34
106
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
34.1
10.4
13
5
XX3DW
NOMESCO Finland
Time consuming IT work
20.7
10.3
15
10
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.7
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.7
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.7
9
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
8.7
9.3
22
41
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
34.3
8.9
11
*
JN4AD
NOMESCO Finland
Body CT examination
34.3
8.9
11
*
A04AD12
ATC
aprepitant; systemic
+∞
8.6
8
*
LEC00
NOMESCO Finland
Partial excision of vagina
+∞
8.6
8
*
WW500
NOMESCO Finland
Blood transfusion
40.6
8.4
10
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
15.4
8.1
13
11
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.7
8.0
18
30
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.5
7
*
C52.92
ICD-10 Finland
Adenocarcinoma of the vagina
+∞
7.5
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
7.5
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.5
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.5
7
*
N02AA05
ATC
oxycodone; systemic
8.0
7.3
17
30
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.3
7.1
28
97
LEB10
NOMESCO Finland
Excision of lesion of vagina
46.4
7.0
8
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
31.0
6.4
8
*
F43.29
ICD-10 Finland
Adaptation disorder UNS
31.0
6.4
8
*
X77
ICPC
Malignant neopl genital female other
+∞
6.4
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.4
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.4
6
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
+∞
6.4
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.4
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.4
6
*

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_VAGINA_EXALLC – Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).